Aflac Incorporated (NYSE:AFL) Director Sells $2,436,695.63 in Stock

Aflac Incorporated (NYSE:AFLGet Free Report) Director Masatoshi Koide sold 30,493 shares of the business’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the transaction, the director now directly owns 86,090 shares of the company’s stock, valued at approximately $6,879,451.90. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

Aflac Stock Up 0.6 %

NYSE AFL opened at $79.26 on Thursday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.08 and a current ratio of 0.08. The company has a market capitalization of $46.32 billion, a P/E ratio of 10.23, a P/E/G ratio of 2.09 and a beta of 0.93. Aflac Incorporated has a one year low of $60.20 and a one year high of $86.20. The stock has a 50 day moving average price of $81.45 and a 200-day moving average price of $79.46.

Aflac (NYSE:AFLGet Free Report) last released its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The company had revenue of $3.78 billion for the quarter, compared to analysts’ expectations of $4.44 billion. During the same quarter in the previous year, the company posted $1.29 EPS. As a group, equities analysts predict that Aflac Incorporated will post 6.43 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on AFL. Raymond James upped their price target on shares of Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a research report on Friday, February 2nd. Evercore ISI downgraded Aflac from an “in-line” rating to an “underperform” rating and boosted their price objective for the company from $76.00 to $78.00 in a research note on Thursday, January 4th. UBS Group boosted their price objective on Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a research note on Wednesday, January 10th. Morgan Stanley boosted their price objective on Aflac from $75.00 to $80.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 15th. Finally, The Goldman Sachs Group upped their price target on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research note on Tuesday, January 9th. Two research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $80.36.

Get Our Latest Research Report on AFL

Institutional Trading of Aflac

Several hedge funds and other institutional investors have recently bought and sold shares of AFL. Panagora Asset Management Inc. raised its holdings in Aflac by 36.2% during the 1st quarter. Panagora Asset Management Inc. now owns 23,941 shares of the financial services provider’s stock valued at $1,542,000 after buying an additional 6,369 shares during the period. Blair William & Co. IL increased its stake in Aflac by 6.8% in the first quarter. Blair William & Co. IL now owns 17,268 shares of the financial services provider’s stock worth $1,112,000 after purchasing an additional 1,102 shares during the period. Aviva PLC increased its stake in Aflac by 0.7% in the first quarter. Aviva PLC now owns 210,634 shares of the financial services provider’s stock worth $13,563,000 after purchasing an additional 1,503 shares during the period. Dakota Wealth Management purchased a new position in shares of Aflac during the first quarter valued at $428,000. Finally, Sequoia Financial Advisors LLC increased its stake in shares of Aflac by 7.3% during the first quarter. Sequoia Financial Advisors LLC now owns 6,142 shares of the financial services provider’s stock valued at $396,000 after buying an additional 417 shares during the period. Hedge funds and other institutional investors own 66.75% of the company’s stock.

About Aflac

(Get Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Further Reading

Insider Buying and Selling by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.